LEAD Program Eligibility

All applications must satisfy the following requirements:

  1. Doctoral degree (e.g., PhD, MD, DrPH, or equivalent) in medicine, social or behavioral sciences, nursing, public health, health economics, or related fields.
  2. Assistant professor or assistant research scientist at a medical school with a track record of NIH funding, or assistant professor or assistant research scientist at a national research university as defined by the Carnegie Foundation classification as "Research Universities" with "Very High" (RU/VH) or "High" (RU/H) Research Activity. The applicant must hold an academic appointment that focuses on conducting research rather than an academic appointment that focuses primarily on teaching. Early career research scientists at non-university affiliated research institutions will also be considered, but the institution should have a strong track record of NIH funding.
  3. Racial/ethnic minority background that is underrepresented in the biomedical and behavioral sciences (i.e., African American, Hispanic, American Indian/Alaska Native, Native Hawaiian, or Pacific Islanders) is preferred, but individuals from racial/ethnic minority groups that are not underrepresented in the biomedical and behavioral sciences will also be considered.
  4. Evidence of an established program of research in the field of drug abuse and addictions as demonstrated by peer reviewed publications in the field of drug abuse and addictions, and/or intramural grant support as either a principal investigator or co-investigator, and/or extramural grant support as a co-investigator in the field of drug abuse and the addictions. (Applicants who were a principal investigator on a K award, R03, R21, R34, R01, or a component leader of a center grant will not be considered.)
  5. Per institutional and NIH guidelines, applicants must not have concurrent training appointments. All applicants must be eligible to accept an appointment as a trainee in the eRA Commons xTrain system for the duration of involvement in the program.
  6. Preferred: Reside in the same city or metropolitan area where a NIDA Clinical Trials Network (CTN) Node is located. (For a list of CTN Nodes and locations, visit the NIDA website.)
     

Offers to participate in the LEAD program are contingent upon availability of funding.